Core Viewpoint - *ST Chengchang has gained significant investor attention following its impressive performance in the first half of 2025, with major funds and institutions conducting research on the company due to its strong financial results and positive operational changes [1] Financial Performance - In the first half of 2025, *ST Chengchang achieved operating revenue of 201 million yuan, a substantial increase of 180.16% year-on-year [1] - The company reported a net profit attributable to shareholders of 56.63 million yuan, marking a successful turnaround and significant growth [1] Business Operations - The growth in performance is primarily attributed to the recovery in downstream market demand and the accelerated delivery of key projects across multiple core business segments [1] - The company has seen a continuous release of orders in satellite, airborne, and ground applications, with both the number of orders on hand and major projects experiencing year-on-year growth [1] Product and Market Position - *ST Chengchang specializes in the research, production, sales, and technical services of microwave and millimeter-wave phased array T/R chips, covering a wide range of high-performance products applicable in various fields [2] - The company has established a strong reputation and recognition in the industry, focusing on the independent control of T/R chip solutions and promoting their low-cost, large-scale application [2] Project Development - In the satellite phased array sector, the company's T/R chip products have been widely applied in multiple satellite series, with ongoing projects entering continuous batch delivery phases [3] - The company maintains close cooperation with downstream users in the low Earth orbit satellite field, continuously iterating on satellite communication T/R chip solutions based on customer needs [3] - *ST Chengchang emphasizes its commitment to expanding operational scale and achieving high profitability levels, driven by the significant growth in downstream demand and product application penetration [3]

证券代码：001270 证券简称：*ST铖昌 公告编号：2025-042 浙江铖昌科技股份有限公司 2025年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或者重大遗漏。 特别提示： 1、本次股东大会未出现否决提案的情形。 2、本次股东大会未涉及变更以往股东大会决议。 一、会议召开情况 （2）通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年9月1 日上午9:15-9:25和9:30-11:30，下午13:00-15:00。通过深圳证券交易所互联网投票的 具体时间为：2025年9月1日9:15-15:00期间的任意时间。 2、现场会议召开地点：杭州市西湖区智强路428号云创镓谷研发中心3号楼会议 室。 3、会议召开方式：本次股东大会采取现场投票与网络投票相结合的方式 4、会议召集人：浙江铖昌科技股份有限公司董事会 5、会议主持人：董事长罗珊珊女士 6、会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上 市规则》及《公司章程》等的有关规定。 二、会议出席情况 参加本次股东大会的股东及股东代理人共计 267 人，代表股份 ...

浙江省杭州市西湖区学院路 77 号 黄龙万科中心 A 座 16 楼 邮编：310012 电话：(86-571) 2689-8188 传真：(86-571) 2689-8199 北京君合（杭州）律师事务所 关于浙江铖昌科技股份有限公司 2025 年第一次临时股东大会之法律意见书 致: 浙江铖昌科技股份有限公司 北京君合（杭州）律师事务所（以下简称"本所"）接受浙江铖昌科技股份 有限公司（以下简称"公司"）委托，根据《中华人民共和国证券法》（以下简 称《证券法》）、《中华人民共和国公司法》（以下简称《公司法》）、中国证券监 督管理委员会《上市公司股东会规则》（以下简称《股东会规则》）、《律师事务 所从事证券法律业务管理办法》《律师事务所证券法律业务执业规则》等中华人 民共和国（以下简称"中国"）现行有效的法律、行政法规、规章和规范性文件 （为本法律意见书之目的，不包括香港特别行政区、澳门特别行政区和台湾地 区现行有效的法律、行政法规、规章和规范性文件）和现行有效的《浙江铖昌 科技股份有限公司章程》（以下简称《公司章程》）有关规定，指派律师列席了 公司于 2025 年 9 月 1 日召开的 2025 年第一次临时股 ...

Summary of Key Points from Conference Call Records Company: Horizon Robotics - **Revenue Performance**: In H1 2025, Horizon Robotics reported revenue of 1.57 billion yuan, a year-on-year increase of 68%, exceeding the expected 1.43 billion yuan. Gross profit was 1.02 billion yuan, a 39% increase year-on-year, but slightly below the expected 1.04 billion yuan [1] - **Business Segmentation**: Revenue from automotive products and solutions reached 780 million yuan, up 250% year-on-year, with shipments of 1.98 million units, a 115% increase. Revenue from automotive licensing and services was 740 million yuan, a 6.9% increase year-on-year [1] - **Market Position**: Horizon Robotics is the first domestic company to achieve a shipment volume of over 10 million units in intelligent driving technology, holding market shares of 32.4% in autonomous driving computing solutions and 45.8% in ADAS front-view integrated machines, both ranking first in the market [1] - **Core Partner**: Zhongke Chuangda, which has a joint venture with Horizon Robotics, reported a non-net profit of 49 million yuan in Q2 2025, a 16-fold increase year-on-year, driven by a 136% increase in revenue from AloT business [1] Industry: Satellite Communication - **Government Initiatives**: On August 27, 2025, the Ministry of Industry and Information Technology released guidelines to promote the development of the satellite communication industry, aiming for over 10 million users of direct satellite connections by 2030 [2] - **Market Developments**: Domestic progress includes China Telecom's plan to promote over 30 direct connection models by May 2025, with annual sales expected to exceed 16 million units [2] - **Key Technologies**: Phased array and beamforming technologies are critical for the implementation of direct satellite communication [3] Industry: Medical and Pharmaceutical - **Policy Framework**: The Ministry of Commerce and Jiangsu Provincial Government issued a development plan for the biopharmaceutical industry on August 27, 2025, focusing on innovation in drugs and high-end medical devices [5] - **Market Size**: In 2024, Jiangsu is expected to approve 352 new drugs, including 13 innovative drugs, leading the nation. The biopharmaceutical cluster in Jiangsu is projected to generate revenue of 454.39 billion yuan in 2024, accounting for 15.3% of the national total [5] - **Core Companies**: Weisi Medical, specializing in non-invasive brain-machine interfaces, and Zhaoyan New Drug, which provides non-clinical research services, are highlighted as key players in the sector [5] Company: Dongtian Microelectronics - **Financial Performance**: In H1 2025, Dongtian Microelectronics reported revenue of 376 million yuan, a 42.29% increase year-on-year, with a non-net profit of approximately 49.78 million yuan, up 109.47% [6] - **Product Expansion**: The company is expanding its product offerings in optical communication and consumer electronics, including camera optical components supplied to Huawei [6] Company: Haosi Automotive Electronics - **Strategic Partnership**: Haosi Automotive Electronics has become a key partner of NVIDIA Jetson Thor, focusing on developing control systems for robotics [7] - **Market Trends**: The value of single-vehicle perception systems is increasing, with prices rising from below 1,000 yuan to 3,000-4,000 yuan per unit due to the proliferation of intelligent driving technologies [7] Company: Yunnan Energy Investment - **Renewable Energy Development**: Yunnan Rongyao New Energy is undergoing compliance checks for its integration into Yunnan Energy Investment, which will increase its renewable energy capacity by nearly 50% [8] - **Financial Projections**: Assuming an annual power generation of 1.2 billion kWh and an electricity price of 0.35 yuan per kWh, the projected annual revenue could reach approximately 420 million yuan, with net profits estimated between 150 million to 200 million yuan [8] Company: Zhongxin Group - **Revenue Growth**: In Q2 2025, Zhongxin Group reported revenue of 1.246 billion yuan, a 161% increase year-on-year, driven by land development and industrial investment [9] - **Operational Metrics**: The company has developed a total area of 3 million square meters in industrial parks, with an occupancy rate of 81% [9] Company: Broadcom Integration - **AI Chip Demand**: Broadcom Integration is benefiting from the growing demand for AI chips in smart terminals, with a focus on Wi-Fi MCU and various AI-integrated chips for applications in AI glasses and toys [10]

关于部分限制性股票回购注销完成的公告 证券代码：001270 证券简称：*ST铖昌 公告编号：2025-041 浙江铖昌科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或者重大遗漏。 特别提示： 1、浙江铖昌科技股份有限公司（以下简称"公司"）本次回购注销的限制性 股票数量为1,531,660股，约占回购注销前公司股本总额的0.7376%。本次回购注销 涉及92名激励对象，回购价格为授予价格及银行同期存款利息。首次授予限制性 股票的授予价格为19.76元/股。公司用于本次限制性股票回购的资金总额为 30,265,601.60元加上银行同期存款利息之和，资金来源为自有资金。本次回购注 销完成后，公司股份总数为206,114,901股。 4、2024年5月13日，公司召开2024年第二次临时股东大会，审议通过了《关 于<2024年限制性股票激励计划（草案）>及其摘要的议案》《关于<2024年限制性 股票激励计划实施考核管理办法>的议案》以及《关于提请股东大会授权董事会办 理2024年限制性股票激励计划相关事项的议案》。本次激励计划获得公司2024年第 二次临时 ...

Investment Rating - The report assigns a "Buy-A" investment rating to the company, with a 12-month target price of 53.29 CNY [6]. Core Views - The company has shown a strong revenue recovery, achieving 201 million CNY in revenue for H1 2025, a year-on-year increase of 180.16%. The net profit attributable to shareholders reached 57 million CNY, compared to a loss of 24 million CNY in the same period last year [1]. - The company is experiencing a rapid recovery in downstream demand, with significant increases in projects and orders. The gross margin for H1 2025 was 68.04%, up 13.35 percentage points year-on-year, and the net margin was 28.15%, compared to -33.81% in the same period last year [1]. - The company is focusing on R&D, with a 45% increase in R&D expenditure to 53 million CNY in H1 2025, aligning with trends in miniaturization, lightweight, high integration, and low-cost equipment [2]. Financial Summary - The company is projected to achieve net profits of 115 million CNY, 171 million CNY, and 232 million CNY for the years 2025, 2026, and 2027, respectively, with growth rates of 48.3% and 36.2% in the following years [3]. - The company’s revenue is expected to grow from 426 million CNY in 2025 to 737 million CNY in 2027, reflecting a compound annual growth rate (CAGR) of 29.2% [9]. - The company’s accounts receivable increased by 25% to 615 million CNY, primarily due to the growth in business scale [2].

Group 1 - The stock price of *ST Chengchang (001270) closed at 44.96 yuan on August 25, 2025, with an increase of 3.81% and a turnover rate of 3.42% [1] - The trading volume was 69,600 lots, with a transaction amount of 309 million yuan [1] - The net inflow of main funds was 13.99 million yuan, accounting for 4.52% of the transaction amount, with large orders showing a net inflow of 24.59 million yuan [1] Group 2 - For the latest financial performance, the company reported total operating revenue of 201 million yuan, a year-on-year increase of 180.16%, and a net profit attributable to shareholders of 56.63 million yuan, up 333.23% year-on-year [1] - The company’s current ratio is 16.961, quick ratio is 13.708, and debt-to-asset ratio is 6.22% [1] Group 3 - Zhejiang Chengchang Technology Co., Ltd. was established in 2010 and is located in Hangzhou, primarily engaged in software and information technology services [2] - The company has invested in 2 external enterprises, participated in 23 bidding projects, and holds 3 trademark registrations and 42 patents [2]

Core Viewpoint - *ST Chengchang (001270) reported significant growth in its semi-annual performance, achieving a revenue of 201 million yuan, a year-on-year increase of 180.16%, and a net profit of 56.63 million yuan, marking a successful turnaround from losses [1] Group 1: Financial Performance - The company achieved a revenue of 201 million yuan in the first half of 2025, reflecting a year-on-year growth of 180.16% [1] - The net profit attributable to shareholders reached 56.63 million yuan, indicating a successful turnaround and substantial growth [1] - The growth in performance is attributed to the recovery in downstream market demand and the batch delivery of key projects across multiple core business segments [1] Group 2: Research and Development - The company invested 52.81 million yuan in R&D during the first half of the year, representing a year-on-year increase of 45.01% [1] - The R&D investment supports the development of new equipment across various fields and provides a core technology reserve for future growth [1] - The company is enhancing cost control and automation capabilities, leading to improvements in both production capacity and efficiency, which helps maintain stable gross margins [1] Group 3: Market Position and Product Development - In the satellite field, the company maintains a leading advantage, with projects entering small batch production in 2024 and expanding product models [2] - The company collaborates closely with downstream users in the low Earth orbit satellite sector, focusing on the iterative development of satellite communication T/R chip solutions, with new products now in mass delivery [2] - The company has accumulated a significant number of project reserves in the ground segment and is steadily advancing based on customer rhythms [2] Group 4: Competitive Advantages - The T/R chip, as a core component of phased array wireless transceiver systems, has high technical barriers and qualification requirements [3] - The company has established itself as one of the few private enterprises with tier-three and tier-four supporting capabilities, leveraging years of technical accumulation and a flexible organizational response mechanism [3] - The company has built a solid customer and market foundation within the industry chain, participating in national key projects [3]

Group 1: Company Research - Yiyu Shikong has made significant progress in automotive and dye LCD materials, photoresist resin, PSPI business, and OLED materials, with automotive LCD materials entering mass production and expected to generate tens of millions in revenue by H2 2025 [1] - ST Chengchang has seen a recovery in downstream user demand, with a notable increase in orders and projects, particularly in satellite and low-orbit satellite fields, which are expected to become new growth points [1] - Jibite has focused on user-driven innovation in game development, with successful titles like "Zhang Jian Chuan Shuo" and "Dao You Lai Wa Bao," while also adjusting its business focus and optimizing personnel configuration [2] - Huadong Pharmaceutical has made significant advancements in innovative drug development across various fields, with multiple products entering clinical stages and a growing revenue share from innovative drugs [3] Group 2: Market Insights - The automotive LCD materials market is expected to grow significantly, with Yiyu Shikong's production capacity reaching 200 tons annually and a focus on new customer development [1] - The low-orbit satellite sector is projected to see substantial growth, with ST Chengchang leveraging its technological advantages to meet increasing demand [1] - The gaming industry is experiencing diverse demand and intense competition, prompting companies like Jibite to focus on user needs and innovative gameplay [2] - The innovative drug market is expanding, with Huadong Pharmaceutical's innovative drug business revenue approaching 15% of total revenue in H1 [3] Group 3: Financial Performance - Silver华基金 has an asset management scale of 576.925 billion, ranking 22nd among 210 firms, with a notable performance from its Hong Kong Stock Connect Innovation Drug ETF, which grew by 123.18% in the past year [4]

Group 1: Yuntianhua (云天化) - Yuntianhua's 2025 semi-annual report details phosphate fertilizer exports, phosphate rock prices, and production volumes of phosphate ammonium, among other topics [1] - Phosphate fertilizer exports are strictly adhering to domestic supply and price stability policies, with high sulfur prices impacting costs [1] - The company is progressing with the trial production of Kunyang No. 2 Mine and the exploration of Zhenxiong phosphate mine, which may be injected into the listed company in the future [1] - Phosphate ammonium production and sales have decreased due to product structure adjustments and maintenance [1] - The supply-demand balance for phosphate rock remains tight, with prices expected to stay high in the short term [1] Group 2: *ST Chengchang (铖昌) - The company has seen a significant increase in orders and projects due to recovering downstream user demand [2] - Remote sensing satellite projects are expected to enter small batch production in 2024 and mass production in 2025, indicating substantial growth potential [2] - The company maintains a stable gross profit margin by improving R&D efficiency and optimizing production processes [2] - The average project cycle is shortening as demand increases, with faster acceptance rates [2] - The company has a technological advantage in the low-orbit satellite sector, which is anticipated to be a new growth point [2] Group 3: Desay SV (德赛西威) - Desay SV achieved a revenue of 14.644 billion yuan in the first half of 2025, a year-on-year increase of 25.25%, with a net profit of 1.223 billion yuan, up 45.82% [3] - The company has established overseas branches, with factories in Indonesia and Mexico already in production, and a smart factory in Spain expected to start mass production in 2026 [3] - The smart driving business generated revenue of 4.147 billion yuan, growing 55.49% year-on-year, with the company holding the largest market share in domestic auxiliary driving domain controllers [3] - The smart cockpit business reported sales of 9.459 billion yuan, an 18.76% increase, with new project orders for the fifth-generation platform [3] Group 4: LIZHU Group (丽珠集团) - LIZHU Group anticipates single-digit revenue growth for the year, with profit growth expected to outpace revenue [4] - The P-CAB tablet has submitted a listing application, while the injection is expected to be approved in the first half of 2029 [4] - The IL-17A/F is projected to be approved in the first half of 2027, with significant commercialization potential [4] - The micro-sphere product market shows great potential, with plans for long-acting micro-sphere formulations and psychiatric products [4] - The small nucleic acid drug LZHN2408 is progressing rapidly, with enrollment for Phase Ib expected to complete in September [4]